FDA.reportPublic FDA data

dextroamphetamine 13.5 MG in 9 HR Transdermal System

RxCUI
2624701
RxNorm name
dextroamphetamine 13.5 MG in 9 HR Transdermal System
Display name
dextroamphetamine 13.5 MG in 9 HR Transdermal System
Full name
dextroamphetamine 13.5 MG in 9 HR Transdermal System
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XELSTRYMDEXTROAMPHETAMINENoven Therapeutics, LLC0862f02a-72a8-41cc-8845-57cf4974bb6f2025-12-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2624701

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0862f02a-72a8-41cc-8845-57cf4974bb6fdextroamphetamine 13.5 MG in 9 HR Transdermal System [PSN] · 9 HR dextroamphetamine 1.5 MG/HR Transdermal System [SCD] · dextroamphetamine 13.5 MG per 9 HR Transdermal System [SY]317These highlights do not include all the information needed to use XELSTRYM safely and effectively. See full prescribing information for XELSTRYM. XELSTRYM ® (dextroamphetamine) transdermal system, CII Initial U.S. Approval: 197520251223